 |
6 Diseases |  |
0 Trials |
|
0 Trials |  |
7 News |  |
- BIOD 531 / Ipsen
Enrollment change, Trial suspension, Trial primary completion date: A Study Evaluating Safety and Efficacy of BIOD 531 Compared to Humalog (clinicaltrials.gov) - Apr 7, 2016
P2, N=13, Suspended, Sponsor: Biodel
N=130 --> 13 | Active, not recruiting --> Suspended | Trial primary completion date: Jun 2016 --> Feb 2016
- | BIOD 531 / Ipsen
Trial completion: BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 Post-Meal Glucose Control in Patients With Severe Insulin Resistance (clinicaltrials.gov) - Feb 8, 2016
P1/2, N=12, Completed, Sponsor: Biodel
N=130 --> 13 | Active, not recruiting --> Suspended | Trial primary completion date: Jun 2016 --> Feb 2016 Active, not recruiting --> Completed
- | BIOD 531 / Ipsen
Trial completion: Comparison of Postprandial Glucose Control Associated With BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 (clinicaltrials.gov) - Feb 8, 2016
P1/2, N=12, Completed, Sponsor: Biodel
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| BIOD 531 / Ipsen
Enrollment closed: A Study Evaluating Safety and Efficacy of BIOD 531 Compared to Humalog (clinicaltrials.gov) - Aug 2, 2015
P2, N=130, Active, not recruiting, Sponsor: Biodel
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ||||| BIOD 531 / Ipsen
New P2 trial: A Study Evaluating Safety and Efficacy of BIOD 531 Compared to Humalog (clinicaltrials.gov) - May 15, 2015
P2, N=130, Recruiting, Sponsor: Biodel
- | BIOD 531 / Ipsen
New P1/2 trial: BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 Post-Meal Glucose Control in Patients With Severe Insulin Resistance (clinicaltrials.gov) - Dec 25, 2014
P1/2, N=12, Active, not recruiting, Sponsor: Biodel
- | BIOD 531 / Ipsen
New P1/2 trial: Comparison of Postprandial Glucose Control Associated With BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 (clinicaltrials.gov) - Aug 11, 2014
P1/2, N=12, Active, not recruiting, Sponsor: Biodel